Crescent Capital BDC, Inc. (NASDAQ:CCAP) Shares Sold by Captrust Financial Advisors

Captrust Financial Advisors decreased its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report) by 7.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 37,391 shares of the company’s stock after selling 2,869 shares during the quarter. Captrust Financial Advisors owned approximately 0.10% of Crescent Capital BDC worth $719,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Franklin Resources Inc. grew its position in Crescent Capital BDC by 12.8% in the 4th quarter. Franklin Resources Inc. now owns 289,131 shares of the company’s stock worth $5,557,000 after purchasing an additional 32,852 shares during the last quarter. Condor Capital Management grew its position in Crescent Capital BDC by 4.7% in the 4th quarter. Condor Capital Management now owns 284,055 shares of the company’s stock worth $5,460,000 after purchasing an additional 12,852 shares during the last quarter. Wells Fargo & Company MN grew its position in Crescent Capital BDC by 0.5% in the 4th quarter. Wells Fargo & Company MN now owns 253,182 shares of the company’s stock worth $4,866,000 after purchasing an additional 1,210 shares during the last quarter. Raymond James Financial Inc. bought a new position in Crescent Capital BDC in the 4th quarter worth about $3,750,000. Finally, Denali Advisors LLC grew its position in Crescent Capital BDC by 0.5% in the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock worth $3,532,000 after purchasing an additional 855 shares during the last quarter. Institutional investors and hedge funds own 49.46% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on CCAP. Raymond James decreased their target price on shares of Crescent Capital BDC from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Friday. Wells Fargo & Company decreased their target price on shares of Crescent Capital BDC from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday. Finally, Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $18.50 to $17.00 in a report on Friday. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $17.60.

Get Our Latest Report on CCAP

Crescent Capital BDC Trading Down 3.3%

Crescent Capital BDC stock opened at $15.42 on Friday. The firm has a 50 day simple moving average of $16.19 and a 200-day simple moving average of $18.07. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. The stock has a market capitalization of $571.47 million, a PE ratio of 7.75 and a beta of 0.63. Crescent Capital BDC, Inc. has a 12-month low of $13.54 and a 12-month high of $20.19.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last posted its quarterly earnings data on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($0.07). The company had revenue of $42.13 million during the quarter, compared to the consensus estimate of $45.08 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. As a group, equities research analysts expect that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Monday, June 30th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 10.89%. The ex-dividend date of this dividend is Monday, June 30th. Crescent Capital BDC’s payout ratio is 84.42%.

Crescent Capital BDC Profile

(Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Articles

Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report).

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.